Mark Reddish

Geschäftsführer bei Metrodora Therapeutics, Inc.

69 Jahre

Health Technology

Consumer Services

Health Services

Aktive Positionen von Mark Reddish

Unternehmen	Position	Beginn	Ende
Metrodora Therapeutics, Inc.	Geschäftsführer	-	-

Unternehmen	Position	Beginn	Ende
MARKER THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	22.11.2011	17.10.2018
	Independent Dir/Board Member	22.11.2011	17.10.2018
	Corporate Officer/Principal	22.11.2011	-
ID Biomedical Corp. ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.	Corporate Officer/Principal	01.01.1998	01.01.2005
Biomira, Inc. Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy	Corporate Officer/Principal	01.01.1991	01.01.1998

University of Massachusetts

Undergraduate Degree

International

Vereinigte Staaten	4
Kanada	3

Operativ

Corporate Officer/Principal	3
Director/Board Member	1
Independent Dir/Board Member	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
MARKER THERAPEUTICS, INC.	Health Technology

Private Unternehmen	3
Metrodora Therapeutics, Inc.
ID Biomedical Corp. ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.	Health Technology
Biomira, Inc. Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy	Health Services